📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Comet Therapeutics

1.1 - Company Overview

Comet Therapeutics Logo

Comet Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapies designed to treat orphan neurological disorders; develops treatments to restore dysregulated CoEnzyme A metabolism through a CoEnzyme metabolism platform, enabling physicians to address profound unmet medical needs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Comet Therapeutics

Rallybio Logo

Rallybio

HQ: United States Website
  • Description: Provider of biotechnological R&D services developing investigational therapies, including RLYB212 to prevent HPA-1a alloimmunization in expectant mothers at higher risk of FNAIT; RLYB116, a self-delivered C5-targeting antibody mimetic; RLYB114, a C5-targeted Affibody for ophthalmic diseases; RLYB331, a monoclonal antibody targeting MTP-2 for iron overload; and an ENPP1 inhibitor program for hypophosphatasia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rallybio company profile →
ApcinteX Logo

ApcinteX

HQ: United Kingdom Website
  • Description: Provider of therapies that modulate the anticoagulant APC pathway to treat haemophilia, developing a drug that turns down this pathway to restore normal blood clotting, with potential applicability across all haemophilia types.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ApcinteX company profile →
Spruce Biosciences Logo

Spruce Biosciences

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for rare endocrine diseases, including tildacerfont, a CRF1 receptor antagonist in late-stage clinical trials for classic congenital adrenal hyperplasia and potentially other conditions with elevated ACTH. Conducts CAHMELIA 203, a double-blind, placebo-controlled, dose-ranging study evaluating tildacerfont's efficacy and safety in adults with CAH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spruce Biosciences company profile →
Mereo Biopharma Logo

Mereo Biopharma

HQ: United Kingdom Website
  • Description: Provider of UK-based specialty biopharmaceutical development and funding of novel, specialist-focused products sourced from large pharmaceutical and biotechnology companies. Portfolio includes Setrusumab for osteogenesis imperfecta, Alvelestat for AATD-associated lung disease, Etigilimab for advanced solid tumors, Navixizumab for post-platinum ovarian cancer, and Leflutrozole for hormonal disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mereo Biopharma company profile →
Aeovian Pharmaceuticals Logo

Aeovian Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutics for rare and age-related diseases, focused on discovering, developing, and commercializing treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aeovian Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Comet Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Comet Therapeutics

2.2 - Growth funds investing in similar companies to Comet Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Comet Therapeutics

4.2 - Public trading comparable groups for Comet Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Comet Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Comet Therapeutics

What does Comet Therapeutics do?

Comet Therapeutics is a provider of therapies designed to treat orphan neurological disorders; develops treatments to restore dysregulated CoEnzyme A metabolism through a CoEnzyme metabolism platform, enabling physicians to address profound unmet medical needs.

Who are Comet Therapeutics's competitors?

Comet Therapeutics's competitors and similar companies include Rallybio, ApcinteX, Spruce Biosciences, Mereo Biopharma, and Aeovian Pharmaceuticals.

Where is Comet Therapeutics headquartered?

Comet Therapeutics is headquartered in United States.

How many employees does Comet Therapeutics have?

Comet Therapeutics has 1,000 employees 🔒.

When was Comet Therapeutics founded?

Comet Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Comet Therapeutics in?

Comet Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Comet Therapeutics

Who are the top strategic acquirers in Comet Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Comet Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Comet Therapeutics?

Top strategic M&A buyers groups and sectors for Comet Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Comet Therapeutics's sector and industry vertical

Which are the top PE firms investing in Comet Therapeutics's sector and industry vertical?

Top PE firms investing in Comet Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Comet Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Comet Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Comet Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Comet Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Comet Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Comet Therapeutics?

The key public trading comparables and valuation benchmarks for Comet Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Comet Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Comet Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Comet Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Comet Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Comet Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Comet Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Comet Therapeutics